Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-6228
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGeyer, Martin-
dc.contributor.authorKeller, Karsten-
dc.contributor.authorBorn, Sonja-
dc.contributor.authorBachmann, Kevin-
dc.contributor.authorTamm, Alexander R.-
dc.contributor.authorRuf, Tobias F.-
dc.contributor.authorKreidel, Felix-
dc.contributor.authorHahad, Omar-
dc.contributor.authorAhoopai, Majid-
dc.contributor.authorHobohm, Lukas-
dc.contributor.authorBeiras-Fernandez, Andres-
dc.contributor.authorKornberger, Angela-
dc.contributor.authorSchulz, Eberhard-
dc.contributor.authorMünzel, Thomas-
dc.contributor.authorBardeleben, Ralph Stephan von-
dc.date.accessioned2021-08-02T11:05:42Z-
dc.date.available2021-08-02T11:05:42Z-
dc.date.issued2021-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/6238-
dc.description.abstractOBJECTIVES Transcatheter mitral valve repair (TMVR) by edge-to-edge therapy is an established treatment for severe mitral valve regurgitation (MR). BACKGROUND Symptomatic and prognostic benefit in functional MR has been shown recently; nevertheless, data on long-term outcomes are sparse. METHODS AND RESULTS We analyzed survival of patients treated with isolated edge-to-edge repair from June 2010 to March 2018 (primarily combined edge-to-edge repair with other mitral valve interventions was excluded) in a retrospective monocentric study. Overall, 627 consecutive patients (47.0% females, 78.6 years in mean) were included. Leading etiology was functional MR (57.4%). Follow-up regarding survival was available in 97.0%. While 97.6% were discharged alive, 75.7% were alive after a 1-year, 54.5% after 3-year, 37.6% after 5-year and 21.7% after 7-year follow-up. Higher logistic Euroscores and comorbidities such as COPD and renal insufficiency were associated with higher in-hospital and 1-year mortality. Importantly, in-hospital survival increased over the years. CONCLUSIONS With the present study we established high survival rates at discharge and after 1 year of patients treated with TMVR. This goes along with high implantation numbers, increased interventional experience and a better in-hospital survival over the years. Long-term mortality in turn was substantially influenced by comorbidities.en_GB
dc.language.isoengde
dc.rightsCC BY-NC*
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titlePredictors of short- and long-term outcomes of patients undergoing transcatheter mitral valve edge-to-edge repairen_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-6228-
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleCatheterization and cardiovascular interventionsde
jgu.journal.volume97de
jgu.journal.issue3de
jgu.pages.startE390de
jgu.pages.endE401de
jgu.publisher.year2021-
jgu.publisher.nameWiley Intersciencede
jgu.publisher.placeNew York, NYde
jgu.publisher.urihttps://doi.org/10.1002/ccd.29068de
jgu.publisher.issn1522-726Xde
jgu.organisation.placeMainz-
jgu.subject.ddccode610de
jgu.publisher.doi10.1002/ccd.29068-
jgu.organisation.rorhttps://ror.org/023b0x485-
Appears in collections:JGU-Publikationen

Files in This Item:
  File Description SizeFormat
Thumbnail
geyer_martin-predictors_of_-20210802125931949.pdf300.55 kBAdobe PDFView/Open